Spectacles for correcting irregular astigmatism in patients with keratoconus

ISRCTN ISRCTN15964758
DOI https://doi.org/10.1186/ISRCTN15964758
IRAS number 282471
Secondary identifying numbers UoL001582, IRAS 282471, CPMS 49194
Submission date
13/03/2023
Registration date
28/03/2023
Last edited
03/04/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Keratoconus occurs when the cornea (front surface of the eye) thins and bulges outward into a cone shape, causing blurred vision. This study aims to create spectacle lenses that correct irregular astigmatism for keratoconic patients. As advanced keratoconic patients find difficulty in their daily life when they cannot wear their contact lenses, this study will be a step towards developing spectacles that can maintain a reasonable visual acuity. The study addresses the visual side effects of the resultant distortion with the development of spectacle lenses that can correct non-orthogonal astigmatism. This is not possible with current spectacle lens manufacturing techniques, leaving patients with this condition entirely dependent on contact lenses, or in severe cases, corneal transplants, to achieve reasonable visual acuity.

Who can participate?
Keratoconus patients aged 18 years and over

What does the study involve?
Visual acuity is measured at a single visit with no follow-up.

What are the possible benefits and risks of participating?
Participation has no direct benefit, and risks are minimal as it is like trying a pair of glasses.

Where is the study run from?
Royal Liverpool University Hospital

When is the study starting and how long is it expected to run for?
July 2021 to December 2022

Who is funding the study?
1. Fight for Sight (UK)
2. Keratoconus Group (UK)

Who is the main contact?
Dr Ahmed Abass, amfabass@liverpool.ac.uk

Contact information

Dr Ahmed Abass
Principal Investigator

Department of Mechanical, Materials and Aerospace Engineering
School of Engineering, University of Liverpool
Brownlow Hill
Liverpool
L69 3GH
United Kingdom

ORCiD logoORCID ID 0000-0002-8622-4632
Phone +44 (0)151 794 5229
Email a.abass@liverpool.ac.uk

Study information

Study designProspective controlled observational study
Primary study designObservational
Secondary study designCross sectional study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleSpectacles for correcting irregular astigmatism in keratoconic patients
Study hypothesisAn earlier analytical study indicated that the higher the degree of non-orthogonal astigmatism the larger the benefit to the patient’s visual acuity (Abass, Lopes et al. 2019). This study will assess this prediction and identify those candidates who stand to benefit most from using non-orthogonal lenses. Those candidates will be identified based on their topography power maps. As conventional topographers’ software packages are measuring orthogonal astigmatism only, a special custom-built MATLAB code will be developed to locate the non-orthogonal astigmatism axes and determine if the patient is a good candidate for this treatment.
Ethics approval(s)Approved 08/07/2021, London - Bromley Research Ethics Committee (Temple Quay House, 2 The Square, Temple Quay, Bristol, BS1 6PN, UK; +44 (0)2071048118, +44 (0)2071048140, +44 (0)2071048016; bromley.rec@hra.nhs.uk), ref: 21/PR/0561
ConditionKeratoconus
InterventionVisual acuity is measured at a single visit with no follow-up.
Intervention typeDevice
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)
Primary outcome measureVisual acuity in LOGMAR at refraction (using both letters and lines) measured at a single visit
Secondary outcome measures1. Keratometry measured using a keratometer at a single visit
2. Corneal thickness measured using a Pentacam tomographer at a single visit
3. Corneal profile measured using a Pentacam tomographer at a single visit
4. Aberrometry measured using an aberrometer at a single visit
Overall study start date08/07/2021
Overall study end date31/12/2022

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants15
Total final enrolment15
Participant inclusion criteriaKeratoconus patients aged 18 years and over
Participant exclusion criteria1. Patients unable to fixate on a target
2. Patients under 18 years old
3. Patients with other ocular diseases
4. Pregnant patients
5. Patients with a corneal scar or fibrosis
Recruitment start date15/02/2022
Recruitment end date30/06/2022

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Royal Liverpool University Hospital
W Derby Street
Liverpool
L7 8YA
United Kingdom

Sponsor information

University of Liverpool
University/education

Research Support Office
2nd Floor Block D Waterhouse Building
3 Brownlow Street
Liverpool
L69 3GL
England
United Kingdom

Phone +44 (0)151 794 8739
Email sponsor@liverpool.ac.uk
Website https://www.liverpool.ac.uk/
ROR logo "ROR" https://ror.org/04xs57h96

Funders

Funder type

Charity

Fight for Sight UK
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Fight for Sight
Location
United Kingdom
Keratoconus Group

No information available

Results and Publications

Intention to publish date31/12/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryPublished as a supplement to the results publication
Publication and dissemination planThe results of this study will be published in a research paper
IPD sharing planThe datasets generated and/or analysed during the current study will be published as a supplement to the results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

03/04/2023: Internal review.
28/03/2023: Trial's existence confirmed by the London - Bromley Research Ethics Committee.